Condition - Melasma

What is Melasma?

What is melasma, and how does it show up?

Melasma is a common skin condition that causes dark, discolored patches to form on the skin. These patches are usually brown or grayish and can be found mainly on the face. It typically appears in a symmetrical pattern, meaning the patches show up on both sides of the face in the same areas.

What are the main types of melasma?

There are three main types of melasma, based on how deep the pigment lies in the skin:

  • Epidermal melasma: Pigment is in the top layer of the skin (epidermis), making it easier to treat.

  • Dermal melasma: Pigment is found deeper in the skin (dermis), making treatment more difficult.

  • Mixed melasma: This is the most common type, where pigment is present in both the epidermis and dermis.

Where on the body does melasma most commonly appear?

MMelasma most commonly appears on the face, particularly in areas that are exposed to the sun:

  • Cheeks

  • Forehead

  • Bridge of the nose

  • Upper lip

However, melasma can sometimes appear on other sun-exposed areas, like the neck and forearms.

Who is most likely to develop melasma?

Melasma is more common in:

  • Women, especially during their reproductive years

  • People with darker skin tones (such as those of Hispanic, Asian, and Middle Eastern descent)

  • Individuals with a family history of melasma

  • People who experience hormonal changes, such as during pregnancy or while using birth control pills

What are the most common areas affected by melasma on the face?

The most common areas affected by melasma on the face include:

  • Cheeks

  • Forehead

  • Bridge of the nose

  • Upper lip

  • Chin

Melasma often follows a centrofacial pattern, meaning it occurs in the central part of the face.

Can melasma occur on other parts of the body besides the face?

Yes, while melasma most commonly affects the face, it can also occur on other areas that are frequently exposed to the sun, such as:

  • Neck

  • Forearms

  • Upper chest

However, this is less common compared to facial melasma.

What is the difference between epidermal and dermal melasma?
  • Epidermal melasma involves excess pigment in the top layer of the skin (the epidermis). This type is often easier to treat with creams and treatments that target the skin surface.

  • Dermal melasma involves pigment that is deeper in the skin (the dermis). Because the pigment is located deeper, this type of melasma can be more resistant to treatment and often takes longer to improv

How can you tell if your melasma is epidermal or dermal?

A dermatologist can determine whether your melasma is epidermal or dermal using a special light called a Wood's lamp:

  • Epidermal melasma: The pigmentation will appear brighter under the Wood's lamp, indicating it is in the top layer of the skin.

  • Dermal melasma: The pigmentation may not change much under the lamp, meaning it is deeper in the skin.

Causes of Melasma

What causes melasma to develop?

Melasma develops due to an overproduction of melanin, the pigment that gives color to your skin. This overproduction can be triggered by a combination of factors, including:

  • Sun exposure

  • Hormonal changes

  • Genetics

  • Certain medications These factors cause melanocytes, the cells responsible for melanin, to produce more pigment than usual, leading to the characteristic dark patch

Can sun exposure cause melasma?

Yes, sun exposure is one of the main causes of melasma. The ultraviolet (UV) rays from the sun stimulate melanocytes to produce more pigment. Even short periods in the sun can cause melasma to appear or worsen, which is why it’s essential for people with melasma to use broad-spectrum sunscreen every day.

How do hormonal changes impact the development of melasma?

Hormonal changes play a significant role in triggering melasma. Estrogen and progesterone can stimulate melanocytes, leading to more pigment production. This is why melasma is commonly seen during:

  • Pregnancy (often called "the mask of pregnancy")

  • Birth control pill use

  • Hormone replacement therapy These hormonal shifts can increase the risk of developing melasma or make existing patches darker.

Can pregnancy trigger melasma?

Yes, pregnancy is a well-known trigger for melasma. The hormonal changes during pregnancy, particularly increased levels of estrogen and progesterone, can cause melasma to develop. This form of melasma is often called "chloasma" or "the mask of pregnancy", and it usually appears in the second or third trimester.

Can taking birth control pills cause melasma?

Yes, birth control pills can trigger melasma or make it worse. The hormones in birth control pills, particularly estrogen, can increase melanin production, leading to the dark patches associated with melasma. Women who are predisposed to melasma may notice that it develops or worsens after starting hormonal contraceptives.

How does visible light contribute to melasma?

Visible light, particularly blue light from the sun or even artificial sources like computer screens, can also contribute to melasma. This type of light penetrates deep into the skin and can stimulate melanocytes to produce more pigment, leading to or worsening melasma. It’s important to use sunscreens that also block visible light, such as tinted sunscreens.

Can certain medications make melasma worse?

Yes, certain medications can worsen melasma. Medications that increase sensitivity to sunlight, such as some antibiotics, anti-inflammatory drugs, and diuretics, can make melasma worse by causing the skin to produce more pigment when exposed to the sun. Hormonal medications, such as oral contraceptives or hormone replacement therapy, can also trigger melasma due to their effect on hormone levels.

What role does skin type play in the development of melasma?

Melasma is more common in people with darker skin types (Fitzpatrick skin types III to VI) because they have more active melanocytes, which produce more melanin. However, melasma can occur in all skin types. Individuals with darker skin are also more likely to experience hyperpigmentation after sun exposure or inflammation, making them more prone to melasma.

Diagnosing Melasma

How is melasma diagnosed?

Melasma is usually diagnosed based on its appearance and a physical examination by a dermatologist. The dark, symmetrical patches on the skin, especially on the face, are characteristic of melasma.

What is the Wood's lamp examination, and how is it used in diagnosing melasma?

A Wood's lamp is a special light that emits UV rays to help a dermatologist see how deep the pigment is in the skin. During the exam, the light is held over the affected areas.

  • If the melasma is epidermal (in the outer layer of the skin), the patches will appear brighter under the light.

  • If the melasma is dermal (deeper in the skin), the light won’t make much of a difference, and the patches will not brighten. This test helps determine how deep the pigmentation is and can guide treatment cho

Is a biopsy or skin sample required to diagnose melasma?

A biopsy or skin sample is usually not required to diagnose melasma. Most dermatologists can diagnose melasma by its appearance and the patient’s history. However, in rare or uncertain cases, a dermatologist may perform a biopsy to rule out other conditions. This involves taking a small skin sample and examining it under a microscope to check for increased melanin or melanophages (pigment-containing cells). Still, this is not commonly needed for most cases of melasma.

How does dermoscopy help in diagnosing melasma?

Dermoscopy is a non-invasive technique that uses a special magnifying tool to look closely at the skin. It can help dermatologists see the pigmentation patterns more clearly and assess whether the pigment is in the epidermis, dermis, or both. This tool is particularly useful in distinguishing melasma from other pigmentation disorders and providing a more detailed analysis without needing a biopsy.

Treating Melasma

Overview of Treatments

What are the most common topical treatments for melasma?

The most common topical treatments for melasma include:

  • Hydroquinone: A skin-lightening agent that reduces pigmentation.

  • Triple combination creams: These combine hydroquinone, a retinoid (like tretinoin), and a corticosteroid.

  • Azelaic acid: A gentle, anti-inflammatory cream that helps lighten skin.

  • Vitamin C: An antioxidant that reduces melanin production.

  • Tretinoin (retinoids): Increases skin cell turnover to reduce pigmentation.

  • Corticosteroids: Reduce inflammation and help lighten the skin when used in combination treatments.

These treatments work in different ways to reduce pigmentation and improve skin appearance.

What are the most common oral treatments for melasma?

Oral treatments for melasma are often used alongside topical treatments to improve results. The most common oral treatments include:

  • Tranexamic acid: This is one of the most popular oral treatments for melasma. It works by reducing the formation of blood vessels in the skin, which can contribute to hyperpigmentation. Studies have shown that tranexamic acid can help lighten melasma when used over several months. However, it should be used under a doctor’s supervision due to potential side effects, such as gastrointestinal issues and, in rare cases, blood clots.

  • Polypodium leucotomos: This is a natural extract from a fern plant, known for its antioxidant and photoprotective properties. It helps protect the skin from sun damage and can reduce the severity of melasma. It is often used as a supplement to topical sunscreens for better sun protection.

  • Glutathione: An antioxidant that has been studied for its skin-lightening effects. It works by inhibiting melanin production and has been used orally to help lighten pigmentation, including melasma. However, the effectiveness and safety of oral glutathione for melasma still need further research.

  • Oral antioxidants: Vitamins and supplements, such as vitamin C and alpha-lipoic acid, are sometimes recommended to help reduce oxidative stress, which can worsen melasma. While these supplements may not directly treat melasma, they support overall skin health and can complement other treatments.

Oral treatments for melasma are often used in combination with sun protection and topical therapies for better results. It’s important to consult a dermatologist before starting any oral treatment to ensure it's appropriate for your specific case and to monitor for potential side effects.

Oral Treatments

What is Polypodium leucotomos?

Polypodium leucotomos is a natural extract derived from a type of tropical fern found in Central and South America. It is commonly used in oral supplements for its antioxidant and photoprotective properties, which help protect the skin from damage caused by UV rays and other environmental factors.

Polypodium leucotomos has gained popularity in dermatology because it can:

  • Reduce sun damage: It helps to protect the skin from the harmful effects of UV radiation, which is a key trigger for melasma.

  • Prevent pigmentation: By reducing the production of free radicals and inflammation, it can help minimize the overproduction of melanin, the pigment responsible for dark patches in melasma.

  • Support skin health: As an antioxidant, it helps fight oxidative stress that can damage skin cells and worsen pigmentation issues.

Although Polypodium leucotomos is not a standalone cure for melasma, it is often used as part of a combination treatment. It is particularly useful when taken as an oral supplement along with sunscreen to enhance sun protection and reduce the severity of melasma flare-ups caused by sun exposure.

Are there studies that support the use of Polypodium leucotomos for melasma?

Yes, several studies support the use of Polypodium leucotomos for melasma and other sun-related pigmentation disorders. Research shows that Polypodium leucotomos helps reduce UV-induced skin damage and oxidative stress, which are key triggers for melasma. By protecting the skin from the harmful effects of UV rays, it can help prevent melasma from worsening or returning after treatment.

How does Polypodium leucotomos work for melasma?

Polypodium leucotomos acts as a powerful antioxidant, which helps to reduce oxidative stress and inflammation caused by UV radiation. These factors can activate melanocytes, the cells that produce melanin, leading to more pigmentation. Polypodium leucotomos helps reduce this reaction, making it effective at preventing melasma flare-ups triggered by sun exposure. It is often used alongside sunscreen and topical treatments to enhance results.

Is Polypodium leucotomos safe for long-term use?

Yes, Polypodium leucotomos is considered safe for long-term use, with studies showing no significant side effects when used regularly. However, it’s important to use it as part of a comprehensive sun protection plan that includes sunscreen. While Polypodium leucotomos enhances protection against UV rays, it should not replace sunscreen or other sun protection measures. Always consult a healthcare professional before starting any new supplement, especially if you have underlying health conditions.

Is Polypodium leucotomos safe to use?

Yes, Polypodium leucotomos (PLE) is generally considered safe for most people when used at recommended doses. It has been widely used as an oral supplement for skin protection since the 1980s, and studies have not reported significant adverse effects. However, it’s always recommended to consult a healthcare provider before starting PLE, especially if you have underlying health conditions.

Are there any side effects of Polypodium leucotomos?

Though side effects are rare, some people may experience mild gastrointestinal discomfort such as:

  • Stomach upset

  • Nausea

  • Diarrhea

These side effects are usually mild and can often be reduced by taking PLE with food.

Who should avoid taking Polypodium leucotomos?

People who are pregnant or breastfeeding should avoid taking PLE as its safety during pregnancy and lactation has not been well studied. Additionally, PLE has not been tested extensively in children under 18 years. People on medications for heart function or blood pressure should also consult a healthcare provider before taking PLE due to potential interactions.

Hydroquinone

What is hydroquinone, and how does it work to treat melasma?

Hydroquinone is a skin-lightening agent that works by inhibiting the enzyme tyrosinase, which is essential for melanin production. By reducing melanin production, hydroquinone helps fade dark spots and patches on the skin caused by melasma and other hyperpigmentation conditions.

How long has hydroquinone been used as a treatment for melasma?

Hydroquinone has been used in dermatology for over 50 years as one of the most effective treatments for melasma and other pigmentation disorders. Its longstanding use is due to its proven ability to lighten dark patches of skin.

What concentration of hydroquinone is typically used for melasma treatment?

In clinical studies for melasma treatment, hydroquinone is most commonly used at a concentration of 4%, which is considered highly effective. This concentration is often combined with other agents like tretinoin and corticosteroids to create a triple combination therapy.

How does hydroquinone reduce melanin production?

Hydroquinone reduces melanin production by blocking tyrosinase, the enzyme needed for melanin synthesis. Without this enzyme, less melanin is produced, and over time, the dark patches caused by melasma become lighter. Additionally, hydroquinone inhibits the formation of new melanin in the skin.

Is hydroquinone safe for long-term use?

Hydroquinone can be used safely, but long-term use should be approached cautiously. Dermatologists typically recommend using hydroquinone for no more than 3 to 6 months at a time, with breaks in between, to avoid potential side effects like skin irritation or a rare condition called exogenous ochronosis, where the skin can darken instead of lighten. It’s essential to use it under the supervision of a healthcare professional to ensure safe usage.

Are there any risks associated with using hydroquinone for melasma?

Yes, there are some risks associated with hydroquinone use:

  • Skin irritation: Hydroquinone can cause redness, dryness, or peeling, especially in people with sensitive skin.

  • Exogenous ochronosis: Prolonged use of hydroquinone can, in rare cases, lead to a condition where the skin darkens instead of lightens.

  • Increased sun sensitivity: Hydroquinone can make the skin more vulnerable to UV damage, so strict sun protection is essential when using it.

Can hydroquinone cause skin irritation or other side effects?

Yes, hydroquinone can cause skin irritation, including redness, itching, dryness, and peeling. These side effects are more common in individuals with sensitive skin or when using higher concentrations of hydroquinone. It’s important to apply hydroquinone as directed and combine it with a good moisturizer to minimize irritation. Using sunscreen is also crucial to prevent further sun damage and irritation.

What are the alternatives to hydroquinone for people with sensitive skin?

For those with sensitive skin, or those who cannot tolerate hydroquinone, alternatives include:

  • Azelaic acid: A gentle, anti-inflammatory treatment that also inhibits melanin production.

  • Kojic acid: A natural skin-lightening agent that works by blocking tyrosinase.

  • Niacinamide: Helps reduce pigmentation while being anti-inflammatory and soothing.

  • Vitamin C: An antioxidant that brightens skin and reduces melanin production. These alternatives are less likely to cause irritation and are suitable for long-term use.

How long does it take to see results when using hydroquinone for melasma?

Most people begin to see results from hydroquinone within 4 to 6 weeks, but it may take up to 12 weeks for significant improvement. Consistency is key, as hydroquinone needs to be applied daily for the best results. Using sunscreen and avoiding sun exposure will also help enhance the treatment’s effectiveness.

Why is hydroquinone combined with other treatments for melasma?

Hydroquinone is often combined with other treatments, such as:

  • Tretinoin (retinoids): Enhances skin cell turnover, helping hydroquinone work more effectively.

  • Corticosteroids: Reduce inflammation and minimize irritation caused by hydroquinone.

  • Sunscreen: Protects the skin from UV rays, which can worsen melasma. Combining these treatments helps improve the effectiveness of hydroquinone and reduces the likelihood of side effects like irritation and sun sensitivity. This combination approach, often in the form of a triple combination cream, is considered one of the most effective treatments for melasma.

Triple Combination Cream

What is a triple combination cream, and what are its components?se

A triple combination cream is a topical treatment for melasma that includes three active ingredients:

  • Hydroquinone (4%): A skin-lightening agent that reduces melanin production.

  • Tretinoin (0.05%): A retinoid that increases skin cell turnover and helps hydroquinone penetrate deeper into the skin.

  • Corticosteroid (0.01% fluocinolone acetonide): An anti-inflammatory agent that reduces redness and irritation caused by the other two ingredients.

This combination is designed to address melasma from multiple angles—by lightening dark patches, promoting skin renewal, and reducing inflammation

How does the triple combination cream enhance melasma treatment?

The triple combination cream is more effective than using hydroquinone alone because each ingredient works in synergy:

  • Hydroquinone reduces pigmentation.

  • Tretinoin increases skin cell turnover, allowing faster fading of dark spots.

  • Corticosteroids reduce irritation and inflammation, making the cream more tolerable for long-term use.

Together, these components provide faster and more significant improvements in melasma compared to any single treatment alone.

Why is tretinoin included in triple combination therapy for melasma?

Tretinoin is included in triple combination therapy because it accelerates skin cell turnover, meaning new, healthier skin cells replace old cells more quickly. This helps exfoliate the skin and enhances the penetration of hydroquinone, making it more effective at reducing dark spots. Tretinoin also helps prevent new pigmentation from forming.

What is the role of corticosteroids in triple combination creams for melasma?

Corticosteroids, such as fluocinolone acetonide, are included in triple combination creams to reduce inflammation and irritation that can be caused by the other active ingredients, especially hydroquinone and tretinoin. By minimizing these side effects, corticosteroids make the treatment more tolerable for longer-term use and help prevent skin reactions that might worsen melasma​.

How effective is triple combination cream compared to hydroquinone alone?

The triple combination cream has been shown to be significantly more effective than hydroquinone alone in clinical studies. Because it targets melasma through multiple mechanisms—lightening, exfoliating, and reducing inflammation—it tends to produce faster and more noticeable results, often within 4 to 8 weeks. In one study, 63% of participants saw marked improvement using triple combination therapy, compared to lower results for hydroquinone alone​.

What are the long-term risks of using triple combination cream?

Long-term use of triple combination cream can lead to skin thinning and rebound hyperpigmentation. Skin thinning occurs due to prolonged use of corticosteroids (like fluocinolone acetonide) in the cream, which can make the skin more fragile and prone to injury. Rebound hyperpigmentation happens when the skin darkens after stopping treatment, especially if the cream is overused or applied without proper sun protection. To prevent these risks, healthcare providers typically recommend limiting use to 8-12 weeks and transitioning to maintenance treatments once melasma improves.

How likely are side effects from triple combination cream, and who is most at risk?

The likelihood of experiencing side effects from triple combination cream depends on several factors, including skin type, frequency of use, and sun exposure. People with sensitive skin or darker skin tones (Fitzpatrick skin types IV to VI) may be more prone to irritation or post-inflammatory hyperpigmentation.

Studies suggest that mild irritation like peeling and dryness is fairly common, particularly in the first few weeks of use, but severe side effects like skin thinning or rebound hyperpigmentation are less common and typically occur with long-term, unsupervised use.

Is Fluocinolone Acetonide 0.01% a low, medium, or high potency steroid?

Fluocinolone Acetonide Topical Solution USP, 0.01% is considered a low-potency corticosteroid. Low-potency steroids like fluocinolone acetonide are typically used for sensitive areas of the skin, such as the face, groin, or in children, where stronger steroids might cause side effects like skin thinning or atrophy. These lower-potency steroids are suitable for treating mild inflammatory skin conditions over longer durations with a reduced risk of serious side effects compared to higher-potency steroids.

How does fluocinolone acetonide 0.01% potency compare to hydrocortisone 1% potency?

Fluocinolone acetonide 0.01% is considered a low-potency corticosteroid, but it is stronger than hydrocortisone 1%, which is also classified as a mild-potency corticosteroid.

Are there any precautions for using triple combination cream for darker skin tones?

Yes, people with darker skin tones (Fitzpatrick skin types IV to VI) need to be cautious when using triple combination cream, as they may be more prone to post-inflammatory hyperpigmentation (PIH) if the skin becomes irritated. To minimize this risk:

  • Always use sunscreen with at least SPF 30.

  • Moisturize regularly to prevent dryness and irritation.

  • Consider starting with a lower frequency of application and increasing as tolerated

Azelaic Acid

What is azelaic acid, and how does it work to treat melasma?

Azelaic acid is a naturally occurring acid that helps treat melasma by inhibiting tyrosinase, an enzyme responsible for melanin production. This reduces the appearance of dark spots and hyperpigmentation. Azelaic acid also has anti-inflammatory and antibacterial properties, which improve skin texture.

How effective is azelaic acid compared to hydroquinone?

Azelaic acid (20%) has been found to be as effective as hydroquinone (4%) in treating melasma. Both reduce pigmentation, but azelaic acid generally causes fewer side effects, making it a great option for those who can’t tolerate hydroquinone.

Can azelaic acid be used by people with sensitive skin?

Yes, azelaic acid is gentle and well-suited for people with sensitive skin. Its anti-inflammatory properties help minimize irritation, which is common with other treatments like hydroquinone or tretinoin.

Is azelaic acid safe to use during pregnancy?

Yes, azelaic acid is considered safe to use during pregnancy. Unlike hydroquinone and other stronger depigmenting agents, azelaic acid is classified as a Category B drug by the FDA, meaning animal studies have not shown any harm to the fetus, though controlled studies in pregnant women are limited.

How long does it take for azelaic acid to show results in treating melasma?

Azelaic acid typically takes about 8 to 12 weeks to show visible improvement in melasma. Consistent application over several months is necessary to achieve the best results, and it should be combined with sun protection for optimal outcomes.

Can azelaic acid be used in combination with other treatments for melasma?

Yes, azelaic acid can be used in combination with other melasma treatments such as chemical peels. Combining these treatments can improve results by targeting different pathways in melanin production and skin cell turnover.

How does azelaic acid compare to other topical treatments for melasma?

Compared to other topical treatments like hydroquinone or tretinoin, azelaic acid is a gentler option with fewer side effects, making it a good choice for individuals with sensitive skin or those seeking a safer option during pregnancy. While it may take slightly longer to see results compared to hydroquinone, its safety profile and efficacy make it a strong alternative.

How does the time to see skin changes differ between azelaic acid and hydroquinone?

The time to see noticeable skin changes varies between azelaic acid and hydroquinone. Hydroquinone generally shows results more quickly, with improvements often visible within 4 to 6 weeks of consistent use. In contrast, azelaic acid, while effective, tends to work more slowly, with results typically seen after 8 to 12 weeks of use.

The difference in timing is due to the gentler action of azelaic acid, which reduces pigmentation with fewer side effects like irritation. Hydroquinone, being a stronger depigmenting agent, works faster but carries a higher risk of skin irritation, especially in those with sensitive skin. This slower onset of azelaic acid is often balanced by its better safety profile, particularly for long-term use or in sensitive individuals.

Vitamin C

How does vitamin C help in managing melasma?

Vitamin C is a powerful antioxidant that helps brighten the skin and reduce the appearance of dark spots caused by melasma. It works by neutralizing free radicals that can trigger excess melanin production, which leads to hyperpigmentation.

What role does vitamin C play in inhibiting melanin production?

Vitamin C helps inhibit the enzyme tyrosinase, which is responsible for melanin production. By blocking this enzyme, it reduces the formation of new pigment, helping to lighten dark spots and even out the skin tone.

How effective is vitamin C as a standalone treatment for melasma?

While vitamin C is beneficial for reducing hyperpigmentation, it is generally less effective as a standalone treatment for melasma compared to stronger agents like hydroquinone. However, it can be a good option for those with sensitive skin or for maintaining results after other treatments.

Can vitamin C be combined with other topical treatments for melasma?

Yes, vitamin C can be combined with other treatments like retinoids, hydroquinone, or azelaic acid to enhance its effectiveness. Using vitamin C alongside these treatments can help improve skin texture, brighten the complexion, and reduce irritation.

How long does it take to see results from vitamin C treatments for melasma?

Results from using vitamin C for melasma can take around 8 to 12 weeks to become noticeable. It’s important to use the treatment regularly and in combination with sunscreen for the best results.

Are there any side effects associated with using vitamin C topically for melasma?

Vitamin C is generally well-tolerated, but some users may experience mild irritation, redness, or stinging, especially when using higher concentrations. These side effects usually subside as the skin adjusts to the treatment.

Can vitamin C be used during pregnancy or breastfeeding?

Yes, vitamin C is considered safe to use during pregnancy and breastfeeding. It’s a gentle option for addressing hyperpigmentation during these periods when stronger treatments like hydroquinone are not recommended.

How does vitamin C compare to hydroquinone in treating melasma?

Vitamin C is a gentler option than hydroquinone, making it suitable for people with sensitive skin or for long-term maintenance. However, it usually takes longer to see results with vitamin C compared to hydroquinone. Hydroquinone acts more aggressively on melanin production, often showing visible improvement within 4 to 6 weeks, while vitamin C may take 8 to 12 weeks to produce noticeable results.

In terms of treatment endpoint efficacy, hydroquinone tends to result in more complete depigmentation in severe melasma cases, while vitamin C may result in partial lightening rather than a full reduction in pigment. This means hydroquinone is often preferred for more severe pigmentation issues, whereas vitamin C is better suited for mild to moderate melasma or for maintenance after achieving initial results from stronger treatments.

Ultimately, while both treatments can reduce pigmentation, hydroquinone generally leads to a greater overall reduction in pigmentation, especially in more stubborn cases. However, vitamin C offers the advantage of being safer for long-term use and providing additional benefits, such as improved collagen production and protection from sun damage.

Does vitamin C offer additional skin benefits beyond treating melasma?

Yes, vitamin C provides several other skin benefits, including improving collagen production, which helps reduce fine lines and wrinkles, and protecting the skin from UV damage. It can also enhance the skin’s overall brightness and texture, making it a great addition to any skincare routine.

Steroids and Skin Thinning

How do I know if my skin is thinning from steroid usage?

There are several signs and symptoms to look out for if you suspect that your skin is thinning due to the use of topical steroids, like fluocinolone acetonide or others:

  • Visible veins or blood vessels: One of the first signs of skin thinning (also known as atrophy) is the appearance of telangiectasia, or visible small blood vessels, especially on sensitive areas like the face.

  • Increased fragility: Thinned skin may tear more easily or bruise with minimal pressure or injury.

  • Skin translucency: The affected skin may appear shiny or more translucent than normal, with underlying structures becoming more visible.

  • Stretch marks (striae): Prolonged steroid use can lead to stretch marks, particularly in areas where the skin stretches, like the groin or armpits.

  • Dryness and peeling: Thinned skin often becomes dry, flaky, and more prone to irritation and peeling.

If you notice any of these signs, it’s important to speak with a healthcare provider to determine whether to stop or adjust the treatment. Early detection of skin thinning is key to preventing long-term damage, as thinning can become irreversible if it persists over time.

Can skin thinning be reversed?

Yes, skin thinning caused by topical steroids can sometimes be reversed, but this depends on the severity of the thinning and the duration of steroid use. When steroid use is discontinued early, mild skin thinning can often improve over time, as the skin may regenerate collagen and regain some of its original thickness. However, if the skin has been extensively thinned or if steroid use has been prolonged without breaks, the changes may be permanent.

Can severe or long-term skin thinning from steroid use be reversed?

Unfortunately, severe or long-term skin thinning is usually irreversible. When thinning has progressed to the point where stretch marks (striae) or telangiectasia (visible blood vessels) have developed, the structural damage to the skin is often permanent. Even after discontinuing the steroid, these changes typically do not reverse. It’s essential to monitor skin changes closely and consult a healthcare provider if you notice early signs of thinning.

What is steroid dependency in the skin?

Steroid dependency occurs when the skin becomes reliant on topical corticosteroids to maintain normal appearance and function. When the steroids are stopped, the skin may experience rebound symptoms, including inflammation, redness, and itching, as the skin struggles to regulate itself without the steroid. This condition is sometimes referred to as topical steroid withdrawal (TSW) or red skin syndrome

How does steroid dependency develop?

Steroid dependency develops from the prolonged use of topical corticosteroids, especially if they are used in high-potency formulations or applied to sensitive areas like the face or groin. Over time, the skin adjusts to the steroids, and when they are stopped, the skin reacts by producing severe inflammation or other withdrawal symptoms.

How can steroid dependency be prevented?

What is the typical pattern of withdrawal when stopping topical corticosteroids?

When discontinuing topical corticosteroids (GCs), a common withdrawal pattern can occur. Here's how it typically unfolds:

  1. First flare-up (1 week after stopping): Around one week after stopping treatment, the skin may develop redness (erythema) in the area previously treated with the steroid. This phase can last about two weeks, often followed by skin peeling (desquamation).

  2. Second flare-up (around 2 weeks later): After the initial flare-up resolves, a second flare often appears about two weeks later, with similar symptoms of redness and peeling.

  3. Cyclical pattern: The flare-ups tend to repeat themselves, but over time, the episodes of redness and peeling become shorter, and the periods of resolution (healing) become longer.

  4. Duration depends on steroid use: The length of the entire withdrawal phase is typically proportional to the duration of corticosteroid use. Longer periods of steroid use generally result in longer withdrawal periods with more repeated cycles.

It's important to note that withdrawal symptoms can vary, and they tend to be more pronounced if topical corticosteroids were used for an extended time or on sensitive skin areas. Managing the withdrawal process with the guidance of a healthcare provider can help mitigate these symptoms​.

Can topical treatments help reverse skin atrophy?

Yes, certain topical treatments can help improve skin atrophy, especially by stimulating collagen production.

  • Topical Retinoids: Retinoids (like tretinoin) are well-known for their ability to boost collagen production and promote skin regeneration. Clinical studies show that retinoids can help thicken the epidermis (the outer skin layer) and improve the skin’s elasticity, making them useful in reversing mild skin thinng.

  • Topical Vitamin C: Vitamin C is an antioxidant that can help the skin produce more collagen. Using a vitamin C serum can make the skin firmer and thicker over time. It's often used alongside other treatments, like retinoids, to maximize results.

Are there other medical treatments for skin atrophy?

Yes, there are several medical treatments available for addressing skin atrophy caused by prolonged steroid use. These treatments are particularly effective when initiated early and are supported by clinical research. Here are some options:

  1. Platelet-Rich Plasma (PRP) Therapy PRP involves drawing a small amount of the patient’s blood, processing it to concentrate the platelets, and then injecting it back into the skin. Platelets release growth factors that stimulate collagen and elastin production, which are vital for restoring skin thickness. PRP has been shown to improve skin structure and reduce thinning in cases of steroid-induced atrophy.

  2. Topical Retinoids Topical retinoids, such as tretinoin, are widely used to boost collagen production in the skin. Retinoids accelerate the turnover of skin cells and increase the thickness of the epidermis (the outer skin layer). Clinical studies indicate that retinoids can significantly improve the appearance of atrophied skin by enhancing its elasticity and reducing thinning.

  3. Hyaluronic Acid (HA) Fillers Hyaluronic acid fillers are injectable treatments that temporarily restore volume and thickness to atrophied areas. While they do not provide a permanent solution, HA fillers can improve the overall texture and appearance of the skin, making them useful for more severe cases of skin thinning.

  4. Collagen-Stimulating Laser Treatments Fractional lasers and CO2 lasers are non-invasive therapies that stimulate collagen production and help to improve skin texture. These laser treatments create controlled injuries to the skin, triggering a healing response that increases collagen levels and leads to thicker, healthier skin.

Prescription Treatments for Melasma

TeleTest provides compounded prescriptions for melasma treatment. These are listed below, and you can discuss with your skin provider what is appropriate for you.

TeleTest works with a compounding pharmacy, but you can select any local pharmacy if you wish to obtain your prescription in-person. Most pharmacies do not compound these medications.

Prescription: Hydroquinone 4% Cream

Compound: Hydroquinone 4% Cream in Cetaphil Base

Instructions: Apply a thin layer to affected areas once daily in the evening.

Duration: Use for 12 weeks, then re-evaluate.

Side Effects: Redness, stinging, dryness, or contact dermatitis.

Clinical Study: Gupta, A. K., Gover, M. D., Nouri, K., & Taylor, S. C. (2006). The treatment of melasma: A review of clinical trials. Journal of the American Academy of Dermatology, 55(6), 1048-1065. https://doi.org/10.1016/j.jaad.2006.02.009

Prescription: Triple Combination Cream (Hydroquinone 4%, Tretinoin 0.05%, Fluocinolone acetonide 0.01%)

Compound: Triple Combination Cream (Hydroquinone 4%, Tretinoin 0.05%, Fluocinolone acetonide 0.01%)

Instructions: Apply a small amount to affected areas once nightly.

Duration: Use for 8-12 weeks, then reassess based on skin response.

Side Effects: Dryness, peeling, redness, increased sun sensitivity.

Clinical Study: Torok, H. M., Jones, T., Rich, P., Smith, S., & Tschen, E. (2005). Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: A safe and efficacious 12-month treatment for melasma. Cutis, 75(1), 57-62.

Prescription: Azelaic Acid 20% in Glaxal/Cetaphil Base

Instructions: Apply to affected areas twice daily on clean, dry skin.

Duration: Use for up to 6 months, then reassess.

Side Effects: Mild irritation, itching, or redness.

Clinical Study: Farshi, S. (2011). Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma. Journal of Cosmetic Dermatology, 10(4), 282-287. https://doi.org/10.1111/j.1473-2165.2011.00580.x

Prescription: Vitamin C 20% in Glaxal/Cetaphil Base
  • Instructions: Apply once daily in the morning.

  • Duration: Use continuously for up to 6 months.

  • Side Effects: Mild stinging or irritation.

  • Clinical Study: Kameyama, K., Sakai, C., Kondoh, S., Yonemoto, K., Nishiyama, S., Tagawa, M., & Kobayashi, T. (1996). Inhibitory effect of magnesium l-ascorbyl-2 phosphate (vitamin C) on melanogenesis in vitro and in vivo. Journal of the American Academy of Dermatology, 34(1), 29-33.

Prescription: Kojic Acid 2% in Glaxal/Cetaphil Base
  • Instructions: Apply once daily in the evening to clean, dry skin.

  • Duration: Use for 12 weeks, then reassess.

  • Side Effects: Mild redness, itching, or stinging.

  • Clinical Study: Lim, J. T. (1999). Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatologic Surgery, 25(4), 282-284.

Prescription: Tretinoin 0.05% Cream in Glaxal/Cetaphil Base
  • Instructions: Apply once daily in the evening to affected areas.

  • Duration: Use for up to 24 weeks; assess for irritation.

  • Side Effects: Peeling, redness, dryness, and increased sun sensitivity.

  • Clinical Study: Griffiths, C. E., Finkel, L. J., Ditre, C. M., Hamilton, T. A., Ellis, C. N., & Voorhees, J. J. (1995). Topical tretinoin (retinoic acid) improves melasma: A vehicle-controlled, clinical trial. British Journal of Dermatology, 132(5), 758-764. https://doi.org/10.1111/j.1365-2133.1995.tb08737.x

Prescription: Hydroquinone 4% with Glycolic Acid 10% in Glaxal/Cetaphil Base
  • Instructions: Apply a thin layer once daily in the evening.

  • Duration: Use for 12 weeks, then re-evaluate.

  • Side Effects: Redness, dryness, peeling.

  • Clinical Study: Guevara IL, Pandya AG. (2003). Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in melasma. Int J Dermatol, 42(11), 966-72.

Prescription: Kojic Acid 2% with Glycolic Acid 10% in Glaxal/Cetaphil Base
  • Instructions: Apply once daily in the evening to clean, dry skin.

  • Duration: 12 weeks, then reassess.

  • Side Effects: Mild irritation, redness, or stinging.

  • Clinical Study: Lim JT. (1999). Treatment of melasma using kojic acid in a gel with hydroquinone and glycolic acid. Dermatologic Surgery, 25(4), 282-284.

Tretinoin 0.025% with Hydroquinone 4% in Glaxal/Cetaphil Base
  • Instructions: Apply once daily to the affected areas.

  • Duration: Use for up to 24 weeks.

  • Side Effects: Mild irritation, peeling.

  • Clinical Study: Sarkar, R. (2002). Azelaic acid combined with tretinoin in melasma treatment. Dermatologic Surgery, 28(9), 828-832.

References

List of Evidenced Based Supporting Literature
  1. Castela, E., Archier, E., Devaux, S., Gallini, A., Aractingi, S., Cribier, B., ... & Ortonne, J. P. (2012). Topical corticosteroids in plaque psoriasis: A systematic review of the risk of adrenal axis suppression and skin atrophy. Journal of the European Academy of Dermatology and Venereology, 26(Suppl 3), 47-51. https://doi.org/10.1111/j.1468-3083.2012.04523.x

  2. Vázquez-López, F., & Marghoob, A. A. (2004). Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis. Journal of the American Academy of Dermatology, 51(5), 811-813. https://doi.org/10.1016/j.jaad.2004.05.020

  3. Lubach, D., Rath, J., & Kietzmann, M. (1995). Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application. Dermatology, 190(1), 51-55. https://doi.org/10.1159/000246635

  4. Plensdorf, S., Livieratos, M., & Dada, N. (2017). Pigmentation disorders: Diagnosis and management. American Family Physician, 96(12), 797-804.

  5. Quiñonez, R. L., Agbai, O. N., Burgess, C. M., & Taylor, S. C. (2022). An update on cosmetic procedures in people of color. Part 1: Scientific background, assessment, preprocedure preparation. Journal of the American Academy of Dermatology, 86(4), 715-725. https://doi.org/10.1016/j.jaad.2021.07.081

  6. Quiñonez, R. L., Agbai, O. N., Burgess, C. M., & Taylor, S. C. (2022). An update on cosmetic procedures in people of color. Part 2: Neuromodulators, soft tissue augmentation, chemexfoliating agents, and laser hair reduction. Journal of the American Academy of Dermatology, 86(4), 729-739. https://doi.org/10.1016/j.jaad.2021.07.080

  7. Desai, S. R., Alexis, A. F., Elbuluk, N., Grimes, P. E., Weiss, J., Hamzavi, I. H., & Taylor, S. C. (2024). Best practices in the treatment of melasma with a focus on patients with skin of color. Journal of the American Academy of Dermatology, 90(2), 269-279. https://doi.org/10.1016/j.jaad.2023.07.1045

  8. Preissig, J., Hamilton, K., & Markus, R. (2012). Current laser resurfacing technologies: A review that delves beneath the surface. Seminars in Plastic Surgery, 26(2), 109-116. https://doi.org/10.1055/s-0032-1329413

  9. Moolla, S., & Miller-Monthrope, Y. (2022). Dermatology: How to manage facial hyperpigmentation in skin of color. Drugs in Context, 11, Article 2021-11-2. https://doi.org/10.7573/dic.2021-11-2

  10. Taylor, S. C. (2023). Diagnosing skin diseases in skin of color. Dermatologic Clinics, 41(1), xiii-xv. https://doi.org/10.1016/j.det.2023.03.001

  11. Wang, R. F., Ko, D., Friedman, B. J., & Mohammad, T. F. (2023). Disorders of hyperpigmentation: Part I. Pathogenesis and clinical features of common pigmentary disorders. Journal of the American Academy of Dermatology, 88(2), 271-288. https://doi.org/10.1016/j.jaad.2022.01.051

  12. Ko, D., Wang, R. F., Ozog, D., Lim, H. W., & Mohammad, T. F. (2023). Disorders of hyperpigmentation: Part II. Review of management and treatment options for hyperpigmentation. Journal of the American Academy of Dermatology, 88(2), 291-320. https://doi.org/10.1016/j.jaad.2021.12.065

  13. Nasrollahi, S. A., Nematzadeh, M. S., Samadi, A., Ayatollahi, A., Yadangi, S., Abels, C., & Firooz, A. (2019). Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin. Clinical, Cosmetic and Investigational Dermatology, 12, 437-444. https://doi.org/10.2147/CCID.S202285

  14. Rendon, M. I., Gaviria, J. I., & Taylor, S. C. (2006). Efficacy of 20% azelaic acid cream compared with hydroquinone for treating melasma. Journal of Clinical and Aesthetic Dermatology, 9(3), 19-24.

  15. Draelos, Z. D. (2006). Azelaic acid: What is its role in melasma treatment? Cosmetic Dermatology, 5(11), 63-68.

  16. Kircik, L. H. (2011). Azelaic acid 20% cream: A treatment overview for melasma. Journal of Drugs in Dermatology, 10(5), 1-5.

  17. Dayal S., Sahu P., Dua R. (2017). Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: Efficacy and improvement in quality of life. Journal of Cosmetic Dermatology, 16(1), 35-42. https://doi.org/10.1111/jocd.12260

Last updated